Search

Your search keyword '"Infectieziekten onderzoek1 (Bont)"' showing total 226 results

Search Constraints

Start Over You searched for: Author "Infectieziekten onderzoek1 (Bont)" Remove constraint Author: "Infectieziekten onderzoek1 (Bont)"
226 results on '"Infectieziekten onderzoek1 (Bont)"'

Search Results

1. Age-specific SARS-CoV-2 transmission differed from human rhinovirus in households during the early COVID-19 pandemic

2. Genetic variants for head size share genes and pathways with cancer

3. Workshop on the design and use of clinical trials with multiple endpoints, with a focus on prevention of RSV

4. Respiratory syncytial virus: Time for surveillance across all ages, with a focus on adults

5. Respiratory Syncytial Virus European Laboratory Network 2022 Survey: Need for Harmonization and Enhanced Molecular Surveillance

7. Nasal cathelicidin is expressed in early life and is increased during mild, but not severe respiratory syncytial virus infection

10. A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants

11. Healthcare costs related to respiratory syncytial virus in paediatric intensive care units in the Netherlands: a nationwide prospective observational study (the BRICK study)

12. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data

13. Personalized Infant Risk Prediction for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection Requiring Intensive Care Unit Admission

14. Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus

15. Natural variability of TRAIL, IP-10, and CRP in healthy adults - The 'HERACLES' study

16. Burden of Respiratory Syncytial Virus–Associated Acute Respiratory Infections During Pregnancy

17. Long-term immunity after BNT162b2 mRNA COVID-19 vaccination in pediatric patients with cancer

18. Cerebrospinal fluid inflammatory markers to differentiate between neonatal bacterial meningitis and sepsis: A prospective study of diagnostic accuracy

20. Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study

21. Respiratory Syncytial Virus–Associated Hospitalization in Adults With Comorbidities in 2 European Countries: A Modeling Study

22. Impact of Subgroup Distribution on Seasonality of Human Respiratory Syncytial Virus: A Global Systematic Analysis

23. Respiratory Syncytial Virus–Associated Hospital Admissions by Deprivation Levels Among Children and Adults in Scotland

24. Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control Study

25. IgG1 glycosylation highlights premature aging in Down syndrome

26. RSV neutralizing antibodies in dried blood

27. Underreporting and Misclassification of Respiratory Syncytial Virus–Coded Hospitalization Among Adults in Denmark Between 2015–2016 and 2017–2018

28. Distinct genetic liability profiles define clinically relevant patient strata across common diseases

29. Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs—reducing global inequity

30. Airway epithelial cell response to RSV is mostly impaired in goblet and multiciliated cells in asthma

31. Characteristics of inpatient and outpatient respiratory syncytial virus mortality in Gavi-eligible countries

32. Clinical presentation and outcome of invasive mould disease in paediatric patients with acute lymphoblastic leukaemia

33. Nasopharyngeal microbiota in children is associated with severe asthma exacerbations

34. Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study

35. Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study

36. Disagreement FDA and EMA on RSV Maternal Vaccination: Possible Consequence for Global Mortality

37. Outpatient respiratory syncytial virus infections and novel preventive interventions

38. Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection

39. External Validation of the Discriminative Validity of the ReSVinet Score and Development of Simplified ReSVinet Scores in Secondary Care

40. Incorporating data from multiple endpoints in the analysis of clinical trials: example from RSV vaccines

41. Validity of clinical severity scores for respiratory syncytial virus: a systematic review

42. Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes

43. T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults

44. Single-cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants

45. Maternal diet and human milk composition: an updated systematic review

46. Successful stem cell transplantation in two children with acute leukemia and disseminated, non-resectable Mucorales infection prior to transplantation

47. Schizophrenia-associated somatic copy-number variants from 12,834 cases reveal recurrent NRXN1 and ABCB11 disruptions

48. Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial

50. Maternal vaccination against RSV can substantially reduce childhood mortality in low-income and middle-income countries: A mathematical modeling study

Catalog

Books, media, physical & digital resources